reference.pdf

DAFTAR PUSTAKA

1. Nurdjanah S. Sirosis Hati dalam Buku Ajar Ilmu Penyakit Dalam , edisi IV jilid II,

Jakarta, Pusat penerbitan Departemen Ilmu penyakit dalam FK UI., 2006 hal 445-8

2. Kusumobroto O Hernomo, Sirosis Hati, dalam buku ajar Ilmu Penyakit Hati, edisi I,

Jakarta, Jayabadi, 2007, hal 335-45

3. Petrides AS, Stanley T, Matthews DE Vogt C,Bush AJ LambethH, Insulin

resistance in cirrhosis:prolonged reduction of hyperinsulinemia normalizes insulin

sensitivity. Hepatology 1998; 28:141-9

4. Steppan CM Bailey ST, Bhat S, Brown Ej, Banerjee RR, Wright CM,Patel HR,

Ahima RS,Lazar MA (January 2001) ‘The hormone resistin links obesity to

diabetes” Nature 409(6818):307-12.

5. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C,

Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale FV Jr, Shelton

DL, Hébert CC (August 2000). "FIZZ1, a novel cysteine-rich secreted protein

associated with pulmonary inflammation, defines a new gene family". Embo J. 19

(15): 4046–55.

6. Kusminski CM, da Silva NF, Creely SJ, Fisher FM, Harte AL, Baker AR, Kumar S,

McTernan PG (January 2007). "The in vitro effects of resistin on the innate

immune signaling pathway in isolated human subcutaneous adipocytes". J. Clin.

Endocrinol. Metab. 92 (1): 270–6.

Universitas Sumatera Utara

7. Levy JR, Davenport B, Clore JN, Stevens W (March 2002). "Lipid metabolism and

resistin gene expression in insulin-resistant Fischer 344 rats". Am. J. Physiol.

Endocrinol. Metab. 282 (3): E626–33.

8. Vendrell J, Broch M, Vilarrasa N, Molina A, Gómez JM, Gutiérrez C, Simón I, Soler

J, Richart C (June 2004). "Resistin, adiponectin, ghrelin, leptin, and

proinflammatory cytokines: relationships in obesity". Obes. Res. 12 (6): 962–71.

9. Kakizaki S, Sohara N, Yamazaki Y, Horiguchi H, Kanda D, Kenji K "Elevated

plasma recistin concentration in patients with liver cirrhosis ". Lancet 359 (9300):

46–7.

10. Pang S, Lee Y . "Role of Resistin in inflamation and Inflamation – Related

Deasease ". Obes. Res. 10 (11): 1197–9.

11. Nagaev I, Bokarewa M, Tarkowski A, Smith U (2006). "Human resistin is a

systemic immune-derived proinflammatory cytokine targeting both leukocytes and

adipocytes". 2001; 285: 561–4.

12. Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ

(September 2005). "Human resistin stimulates the pro-inflammatory cytokines

TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway".

Biochem. Biophys. Res. Commun. 334 (4): 1092–101.

13. Komatsu T, Yaguchi I, Tanaka A et al. (2007) “Evaluation of homeostasis model

assessment of insulin resistance (HOMA-IR) index” 12 : 66-75

14. Kadowaki T, Yamauchi T, Adiponectin and adiponectin receptors in insulin

resistance, diabetes, and the metabolic syndrome, the Journal of clin invest 116;

7; 1984-92


15. Picardi Antonio, D’Avola Delia, Diabetes in chronic liver disease: from old concepts

to new evidence, Diabetes Metab Res Rev; 2006; 22: 274-83

16. Alizadeh MHA, Fallahian Farrahnaz, Insulin Resistance in Chronic Hepatitis B and

C, Indian Journal of Gastroenterology 2006 Vol 25:286-288

17. Compean Garcia Diego,Quintana JOJ, Garza MH, Hepatogenous Diabetes,

Current views of an ancient problem, Annals of hepatology, 2009, 8; 13-20

18. Knobler H, Zhornicky T , Tumor Necrosis Alfa induced insulin resistance may

mediate the hepatitis C virus, Diabetes association, American journal of

gastroenterology, 2003; 98, 12: 2751-6

19. Perin, PC, Casseder M, Bozzo C, Bruno A, Mechanism of insulin resistance in

human liver cirrhosis. Evidence of a combined receptor and post receptor defect, J

Clin Invest May 1985; 75: 1659-65

20. Petrides A, Stanley T, Insulin resistance in Cirrhosis : Prolonged reduction of

hyperinsulinemia normalizes insulin sensitivity, Hepatology, 1998; 28; 1: 141-9

21. Compean D, Quintana JOJ, Liver Cirrhosis and diabetes : Risk factor,

pathofisiology clinical implication and management , World J Gastroenterol 2009,

21 ;15: 280-8

22. Letiexe MR, Schreen AJ, Insulin secretion, clearance and action on glucose

metabolism in cirrhotic patients. Journal of clinical endocrinology and metabolism

1993; 1263-6

23. Petridges AS, Vogt C, Schulze-Berge D Matthews D,Strohmeyer G.Patheogenesis

of glucose intolerance and diabetes melitus in cirrhosis.

Hepatology 1994;19:616-27


24. Sohara N, Takagi H , Kakizaki S, Sato K , Mori M. Elevated plasma adiponectin

concentrations in patients with liver cirrhosis correlate with plasma insulin levels.

Liver Int. 2005; 25:28-32.




26. Kershaw EE dan Flier JS . Adipose tissue as an endocrine organ. J Clin Endocrinol

Metab 89: 2548-2556,2004.

27. Steppan CM and Lazzar MA . The current biology of resistin. J intern Med

255:439-447,2004

28. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W, Kerr K, Jones R, Zhu

Q, Considine RV (November 2003). "Serum resistin (FIZZ3) protein is increased in

obese humans". J. Clin. Endocrinol. Metab. 88 (11): 5452–5.

29. Kakizaki S, Sohara N, Yamazaki Y, Horiguchi H, Kanda D, Kenji K "Elevated

plasma recistin concentration in patients with liver cirrhosis ". Journal of

Gastroenterology and Hepatology 23 (2008) 73-77

30. Vendrell J, Broch M, Vilarrasa N, Molina A, Gómez JM, Gutiérrez C, Simón I, Soler

J, Richart C (June 2004). "Resistin, adiponectin, ghrelin, leptin, and

proinflammatory cytokines: relationships in obesity". Obes. Res. 12 (6): 962–71.

31. Milan G, Granzotto M, Scarda A, Calcagno A, Pagano C, Federspil G, Vettor R

(November 2002). "Resistin and adiponectin expression in visceral fat of obese

rats: effect of weight loss". Obes. Res. 10 (11): 1095–103.


32. Compean Garcia Diego,Quintana JOJ, Garza MH, Hepatogenous Diabetes,

Current views of an ancient problem, Annals of hepatology, 2009, 8; 13-20




34. Tacke F, Wustefeld T, Horn R et al. high adiponectin in chronic liver disease and

cholestasis suggest biliary route of adiponectin excretion in vivo . J. Hepatol. 2005;

42:666-73

35. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C,

Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale FV Jr, Shelton

DL, Hébert CC (August 2000). "FIZZ1, a novel cysteine-rich secreted protein

associated with pulmonary inflammation, defines a new gene family". Embo J. 19

(15): 4046–55.

36. Yagmur E, Trautwein C, Tacke F. Resistin serum levels are associated with insulin

resistance, disease severity, clinical complications, and prognosis in patients with

chronic liver disease. Am J Gastroenterol 2006 ; 101 :1244-1252

37. Nolte W, Hartman h , Ramadori G . Glucose metabolism and liver cirrhosis. Exp

Clin Endocrinol Diabetes 1995;103:63-74

38. Petrides AS, Liver disease and diabetes mellitus. Diab rev 1994;2:2-18

39. Bianchi G, Marchesini G, Zoli M, et al . Prognostic Significance of diabetes in

patients with cirrhosis. Hepatology 1994;20:119-25


40. Sud A, Hui JM , Farrell GC,et al. improved prediction of fibrosis in chronic hepatitis

C using measures of insulin resistance in a probability index. Hepatology

2004,39:1239-47

41. Muzzi A, Leandro G , Rubbia-Brandt L, et al. Resistance is associated with liver

fibrosis in non-diabetic chronic hepatitis C patients. J hepatol 2005;42:41-6

42. Patel L . Buckels AC, Kinghorn IJ, et al. Resistin is expressed in human

macrophages and directly regulated by PPAR gamma activators. Biochem Biophys

Res Commun 2003;300:472-6

43. Steppan CM, Bailey ST, Bhat S, et al. hormone resistin links obesity to diabetes.

Nature 2001;255 439-47

44. Banerjee RR, Rangwala SM,Shapiro JS,et al.regulation of fasted blood glucose by

resistin . Science 2004;303:1195-8

45. Kaser S, Kaser A, Sandhofer A , et al. Resistin messenger RNA expression is

increased by proinflammatory cytokines in vitro.Biochem Biophys Res Commun

2003;309:286-90

46. Vendrell J, Broch M, Vilarrasa N , Molina A, Gomez JM, Gutierrez C, Simon I,

Soler J, Richart C(June 2004).”Resistin,adiponectin,ghrelin,leptin,and

proinflamatory cytokines: relationships in obesity”. Obes.Res.12(6):962-71

47. Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, Scherer P, Rossetti

L, Barzilai N (October 2002). "Removal of visceral fat prevents insulin resistance

and glucose intolerance of aging: an adipokine-mediated process?". Diabetes 51

(10): 2951–8. .


48. Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-

derived resistin-like molecule-beta selectively impair insulin action on glucose

production. J Clin Invest 2003; 111: 225–30.

49. Moon B, Kwan JJ, Duddy N, Sweeney G, Begum N. Resistin inhibits glucose

uptake in L6 skeletal muscle cells independent of changes in insulin signaling

components and glut-4 translocation. Am J Physiol Endocrinol Metab 2003;

285:E106–15

50. Kim K-H, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific

secretory factor inhibits adipocyte differentiation. J Biol Chem 2001; 276: 11252–6.

51. Kawashima J, Tsuruzoe K, Motoshima H et al. Insulin downregulates resistin

mRNA through the synthesis of protein(s) that could accelerate the degradation of

resistin mRNA in 3T3-L1 adipocytes. Diabetologia 2003; 46: 231–40.

52. Rajala MW, Lin Y, Ranalletta M et al. Cell type-specific expression and

coregulation of murine resistin and resistin like molecule-alpha in adipose tissue.

Mol Endocrinol 2002;16: 1920–30.

53. Shojima N, Sakoda H, Ogihara T et al. Humoral regulation of resistin expression in

3T3-L1 and mouse adipose cells. Diabetes 2002; 51: 1737–44.

54. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Tumor necrosis factor

alpha is a negative regulator of resistingene expression and secretion in 3T3-L1

adipocytes. Biochem Biophys Res Commun 2001; 288: 1027–31.

55. Lu SC, Shieh WY, Chen CY, Hsu SC, Chen HL. Lipopolysaccharide increases

resistin gene expression in vivo and in vitro. FEBS Lett 2002; 530: 158–62.


56. Mc Ternan CL, Mc Ternan PG, Harte AL, Levick PL, Barnett AH, Kumar S

(January 2002). ”Resistin, central obesity, and type 2 diabetes”. Lancet 359

(9300):46-7.


reference.pdf

Documents